B-type natriuretic peptide as diagnostic and prognostic marker in various forms of acute coronary syndrome

  • Sidra Sadiq Rehman Medical Institute
  • Aamir Ijaz Rehman Medical Institute,Peshawar.
  • Mirza Muhammad Dawood
  • Tayyaba Sadiq Rehman Medical Institute,Peshawar.
Keywords: Acute myocardial infarction, Acute coronary syndrome

Abstract

Objectives: This study was conducted to evaluate the diagnostic and prognostic value of B-type natriuretic peptide (BNP) in different categories of acute coronary syndrome (ACS) patients on arrival.

Methods: This cohort study included 197 patients admitted in Coronary Care Unit (CCU) of Rehman Medical Institute (RMI) Peshawar from January 2020 to June 2020. Patients were categorized in two subgroups. Subgroup-I with BNP below 100pg/mL. Subgroup-II having BNP above 100pg/mL. Samples were obtained on admission from these patients for Cardiac Troponin I (Trop-i), BNP and serum creatinine. BNP samples were analyzed on Cobas® using chemiluminescence method. Descriptive statistics were derived for age; gender and cardiac biomarkers. Receiver-operating characteristic curves (ROC) were generated. Diagnostic accuracy parameters were determined for Non ST- segment elevation myocardial infarction (STEMI), ST- segment elevation myocardial infarction (STEMI) and unstable angina (UA).

Result: One hundred fourteen patients (58.2%) were males and 82 were females (41.8%).Our of this 89 patients were NSTEMI in group II. Mean BNP was 1438±1463.Age distribution shows 120 individuals were over 55 years (61.2%). Hypertension, diabetes, smoking and previous infarcts were the risk factors for ACS. Sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive value (NPV), likelihood ratios, and overall accuracy of BNP at admission for the entire sub categories in ACS (cut-off value 100 pg/mL) were determined by using Trop-i the gold standard. ROC curve showed AUC = 0.557, (95% confidence interval: 0.476–0.638). When Pearson correlation was applied, BNP was found to be a noteworthy independent predictor.

Conclusion: BNP can be a useful Biomarker along with standard cardiac biomarkers in various categories of patients with ACS.

doi: https://doi.org/10.12669/pjms.38.4.4910

How to cite this:
Sadiq S, Ijaz A, Dawood MM, Sadiq T. B-type natriuretic peptide as diagnostic and prognostic marker in various forms of acute coronary syndrome. Pak J Med Sci. 2022;38(4):970-975. doi: https://doi.org/10.12669/pjms.38.4.4910

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Biographies

Sidra Sadiq, Rehman Medical Institute

Dr Sidra Sadiq is working as Chemical pathology Resident at Rehman Medical Institute,Peshawar.

Aamir Ijaz, Rehman Medical Institute,Peshawar.

Prof Aamir Ijaz is working as consultant chemical pathology and endocrinology at Rehman Medical Institute.

Mirza Muhammad Dawood

Prof Mirza Muhammad  Dawood is working as consultant chemical pathology and endocrinology at Rehman Medical Institute,Peshawar.

Tayyaba Sadiq, Rehman Medical Institute,Peshawar.

Miss Tayyaba Sadiq is BS MLT Student at Rehman Medical Institute,Peshawar.

Published
2022-03-07
How to Cite
Sadiq, S., Ijaz, A., Dawood, M. M., & Sadiq, T. (2022). B-type natriuretic peptide as diagnostic and prognostic marker in various forms of acute coronary syndrome. Pakistan Journal of Medical Sciences, 38(4). https://doi.org/10.12669/pjms.38.4.4910